BindingDB logo
myBDB logout

Patent code US10221182

Compile Data Set for Download or QSAR
Found 98 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361999
PNG
(US10221182, Compound E1-1.6 | US10221182, Compound...)
Show SMILES FC(F)[H]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H21F4N6/c20-18(21)30-13-3-1-12(2-4-13)5-7-29-8-6-15(19(22,23)10-29)27-16-14-9-26-28-17(14)25-11-24-16/h1-4,9,11,15,18H,5-8,10H2,(H2,24,25,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361999
PNG
(US10221182, Compound E1-1.6 | US10221182, Compound...)
Show SMILES FC(F)[H]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H21F4N6/c20-18(21)30-13-3-1-12(2-4-13)5-7-29-8-6-15(19(22,23)10-29)27-16-14-9-26-28-17(14)25-11-24-16/h1-4,9,11,15,18H,5-8,10H2,(H2,24,25,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361999
PNG
(US10221182, Compound E1-1.6 | US10221182, Compound...)
Show SMILES FC(F)[H]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H21F4N6/c20-18(21)30-13-3-1-12(2-4-13)5-7-29-8-6-15(19(22,23)10-29)27-16-14-9-26-28-17(14)25-11-24-16/h1-4,9,11,15,18H,5-8,10H2,(H2,24,25,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361992
PNG
(US10221182, Compound E1-1.4 | US10221182, Compound...)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F2N6/c1-13-2-4-14(5-3-13)6-8-27-9-7-16(19(20,21)11-27)25-17-15-10-24-26-18(15)23-12-22-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 18.5n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361992
PNG
(US10221182, Compound E1-1.4 | US10221182, Compound...)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F2N6/c1-13-2-4-14(5-3-13)6-8-27-9-7-16(19(20,21)11-27)25-17-15-10-24-26-18(15)23-12-22-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 18.5n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361999
PNG
(US10221182, Compound E1-1.6 | US10221182, Compound...)
Show SMILES FC(F)[H]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H21F4N6/c20-18(21)30-13-3-1-12(2-4-13)5-7-29-8-6-15(19(22,23)10-29)27-16-14-9-26-28-17(14)25-11-24-16/h1-4,9,11,15,18H,5-8,10H2,(H2,24,25,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 21.2n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361999
PNG
(US10221182, Compound E1-1.6 | US10221182, Compound...)
Show SMILES FC(F)[H]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H21F4N6/c20-18(21)30-13-3-1-12(2-4-13)5-7-29-8-6-15(19(22,23)10-29)27-16-14-9-26-28-17(14)25-11-24-16/h1-4,9,11,15,18H,5-8,10H2,(H2,24,25,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 21.2n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361999
PNG
(US10221182, Compound E1-1.6 | US10221182, Compound...)
Show SMILES FC(F)[H]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H21F4N6/c20-18(21)30-13-3-1-12(2-4-13)5-7-29-8-6-15(19(22,23)10-29)27-16-14-9-26-28-17(14)25-11-24-16/h1-4,9,11,15,18H,5-8,10H2,(H2,24,25,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 21.2n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361992
PNG
(US10221182, Compound E1-1.4 | US10221182, Compound...)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F2N6/c1-13-2-4-14(5-3-13)6-8-27-9-7-16(19(20,21)11-27)25-17-15-10-24-26-18(15)23-12-22-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361992
PNG
(US10221182, Compound E1-1.4 | US10221182, Compound...)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F2N6/c1-13-2-4-14(5-3-13)6-8-27-9-7-16(19(20,21)11-27)25-17-15-10-24-26-18(15)23-12-22-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362001
PNG
(US10221182, Compound E1-1.7 | US10221182, Compound...)
Show SMILES C[F]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F3N6/c1-22-14-4-2-13(3-5-14)6-8-28-9-7-16(19(20,21)11-28)26-17-15-10-25-27-18(15)24-12-23-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 22.4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362001
PNG
(US10221182, Compound E1-1.7 | US10221182, Compound...)
Show SMILES C[F]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F3N6/c1-22-14-4-2-13(3-5-14)6-8-28-9-7-16(19(20,21)11-28)26-17-15-10-25-27-18(15)24-12-23-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 22.4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362001
PNG
(US10221182, Compound E1-1.7 | US10221182, Compound...)
Show SMILES C[F]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F3N6/c1-22-14-4-2-13(3-5-14)6-8-28-9-7-16(19(20,21)11-28)26-17-15-10-25-27-18(15)24-12-23-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 22.4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM280739
PNG
(US10030026, Compound LX-1 | US10221182, Compound L...)
Show SMILES FC(F)(F)c1ccc(cc1)C(F)(F)CN1CCC(CC1)Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C19H19F5N6/c20-18(21,12-1-3-13(4-2-12)19(22,23)24)10-30-7-5-14(6-8-30)28-16-15-9-27-29-17(15)26-11-25-16/h1-4,9,11,14H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 24n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM280739
PNG
(US10030026, Compound LX-1 | US10221182, Compound L...)
Show SMILES FC(F)(F)c1ccc(cc1)C(F)(F)CN1CCC(CC1)Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C19H19F5N6/c20-18(21,12-1-3-13(4-2-12)19(22,23)24)10-30-7-5-14(6-8-30)28-16-15-9-27-29-17(15)26-11-25-16/h1-4,9,11,14H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 24n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361989
PNG
(US10221182, Compound E1-1.3 | US10221182, Compound...)
Show SMILES FC1(F)CN(CCc2ccc(Cl)cc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H19ClF2N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 25n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361989
PNG
(US10221182, Compound E1-1.3 | US10221182, Compound...)
Show SMILES FC1(F)CN(CCc2ccc(Cl)cc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H19ClF2N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 25n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361989
PNG
(US10221182, Compound E1-1.3 | US10221182, Compound...)
Show SMILES FC1(F)CN(CCc2ccc(Cl)cc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H19ClF2N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 25n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362003
PNG
(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Show SMILES Fc1cc(Cl)ccc1CCN1CCC(Nc2ncnc3[nH]ncc23)C(F)(F)C1
Show InChI InChI=1S/C18H18ClF3N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 27.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362003
PNG
(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Show SMILES Fc1cc(Cl)ccc1CCN1CCC(Nc2ncnc3[nH]ncc23)C(F)(F)C1
Show InChI InChI=1S/C18H18ClF3N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 27.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362003
PNG
(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Show SMILES Fc1cc(Cl)ccc1CCN1CCC(Nc2ncnc3[nH]ncc23)C(F)(F)C1
Show InChI InChI=1S/C18H18ClF3N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 27.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361989
PNG
(US10221182, Compound E1-1.3 | US10221182, Compound...)
Show SMILES FC1(F)CN(CCc2ccc(Cl)cc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H19ClF2N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 31.7n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361989
PNG
(US10221182, Compound E1-1.3 | US10221182, Compound...)
Show SMILES FC1(F)CN(CCc2ccc(Cl)cc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H19ClF2N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 31.7n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361989
PNG
(US10221182, Compound E1-1.3 | US10221182, Compound...)
Show SMILES FC1(F)CN(CCc2ccc(Cl)cc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H19ClF2N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 31.7n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 32.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 32.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 32.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 37.8n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 37.8n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 37.8n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362001
PNG
(US10221182, Compound E1-1.7 | US10221182, Compound...)
Show SMILES C[F]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F3N6/c1-22-14-4-2-13(3-5-14)6-8-28-9-7-16(19(20,21)11-28)26-17-15-10-25-27-18(15)24-12-23-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 38.1n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362001
PNG
(US10221182, Compound E1-1.7 | US10221182, Compound...)
Show SMILES C[F]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F3N6/c1-22-14-4-2-13(3-5-14)6-8-28-9-7-16(19(20,21)11-28)26-17-15-10-25-27-18(15)24-12-23-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 38.1n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362003
PNG
(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Show SMILES Fc1cc(Cl)ccc1CCN1CCC(Nc2ncnc3[nH]ncc23)C(F)(F)C1
Show InChI InChI=1S/C18H18ClF3N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 61.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362003
PNG
(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Show SMILES Fc1cc(Cl)ccc1CCN1CCC(Nc2ncnc3[nH]ncc23)C(F)(F)C1
Show InChI InChI=1S/C18H18ClF3N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 61.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361991
PNG
(US10221182, Compound C-1.2)
Show SMILES Fc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C18H19F3N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 68.3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361991
PNG
(US10221182, Compound C-1.2)
Show SMILES Fc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C18H19F3N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 68.3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361991
PNG
(US10221182, Compound C-1.2)
Show SMILES Fc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C18H19F3N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 68.3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362005
PNG
(US10221182, Compound E1-1.11)
Show SMILES FC(F)(F)Oc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6O/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)31-19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 68.4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM362005
PNG
(US10221182, Compound E1-1.11)
Show SMILES FC(F)(F)Oc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6O/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)31-19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 68.4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361995
PNG
(US10221182, Compound C-1.34)
Show SMILES Cc1n[nH]c2ncnc(NC3CCN(CCc4ccc(cc4)C(F)(F)F)CC3(F)F)c12
Show InChI InChI=1S/C20H21F5N6/c1-12-16-17(26-11-27-18(16)30-29-12)28-15-7-9-31(10-19(15,21)22)8-6-13-2-4-14(5-3-13)20(23,24)25/h2-5,11,15H,6-10H2,1H3,(H2,26,27,28,29,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 72.8n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361995
PNG
(US10221182, Compound C-1.34)
Show SMILES Cc1n[nH]c2ncnc(NC3CCN(CCc4ccc(cc4)C(F)(F)F)CC3(F)F)c12
Show InChI InChI=1S/C20H21F5N6/c1-12-16-17(26-11-27-18(16)30-29-12)28-15-7-9-31(10-19(15,21)22)8-6-13-2-4-14(5-3-13)20(23,24)25/h2-5,11,15H,6-10H2,1H3,(H2,26,27,28,29,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 72.8n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361994
PNG
(US10221182, Compound C-1.15)
Show SMILES Fc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c(F)c1
Show InChI InChI=1S/C18H18F4N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 78.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361994
PNG
(US10221182, Compound C-1.15)
Show SMILES Fc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c(F)c1
Show InChI InChI=1S/C18H18F4N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 78.9n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361984
PNG
(US10221182, Compound C-1.1 | US10221182, Compound ...)
Show SMILES FC1(F)CN(CCc2ccccc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H20F2N6/c19-18(20)11-26(8-6-13-4-2-1-3-5-13)9-7-15(18)24-16-14-10-23-25-17(14)22-12-21-16/h1-5,10,12,15H,6-9,11H2,(H2,21,22,23,24,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 83.8n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361984
PNG
(US10221182, Compound C-1.1 | US10221182, Compound ...)
Show SMILES FC1(F)CN(CCc2ccccc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H20F2N6/c19-18(20)11-26(8-6-13-4-2-1-3-5-13)9-7-15(18)24-16-14-10-23-25-17(14)22-12-21-16/h1-5,10,12,15H,6-9,11H2,(H2,21,22,23,24,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 83.8n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361984
PNG
(US10221182, Compound C-1.1 | US10221182, Compound ...)
Show SMILES FC1(F)CN(CCc2ccccc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H20F2N6/c19-18(20)11-26(8-6-13-4-2-1-3-5-13)9-7-15(18)24-16-14-10-23-25-17(14)22-12-21-16/h1-5,10,12,15H,6-9,11H2,(H2,21,22,23,24,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 98.8n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361984
PNG
(US10221182, Compound C-1.1 | US10221182, Compound ...)
Show SMILES FC1(F)CN(CCc2ccccc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H20F2N6/c19-18(20)11-26(8-6-13-4-2-1-3-5-13)9-7-15(18)24-16-14-10-23-25-17(14)22-12-21-16/h1-5,10,12,15H,6-9,11H2,(H2,21,22,23,24,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 98.8n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361986
PNG
(US10221182, Compound C-1.33)
Show SMILES CN(C1CCN(CCc2ccc(cc2)C(F)(F)F)CC1(F)F)c1ncnc2[nH]ncc12
Show InChI InChI=1S/C20H21F5N6/c1-30(18-15-10-28-29-17(15)26-12-27-18)16-7-9-31(11-19(16,21)22)8-6-13-2-4-14(5-3-13)20(23,24)25/h2-5,10,12,16H,6-9,11H2,1H3,(H,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 103n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361986
PNG
(US10221182, Compound C-1.33)
Show SMILES CN(C1CCN(CCc2ccc(cc2)C(F)(F)F)CC1(F)F)c1ncnc2[nH]ncc12
Show InChI InChI=1S/C20H21F5N6/c1-30(18-15-10-28-29-17(15)26-12-27-18)16-7-9-31(11-19(16,21)22)8-6-13-2-4-14(5-3-13)20(23,24)25/h2-5,10,12,16H,6-9,11H2,1H3,(H,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 103n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361985
PNG
(US10221182, Compound C-2.5)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ccc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C20H20F5N5/c21-19(22)11-30(9-6-13-1-3-14(4-2-13)20(23,24)25)10-7-16(19)29-18-15-5-8-26-17(15)27-12-28-18/h1-5,8,12,16H,6-7,9-11H2,(H2,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 105n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361985
PNG
(US10221182, Compound C-2.5)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ccc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C20H20F5N5/c21-19(22)11-30(9-6-13-1-3-14(4-2-13)20(23,24)25)10-7-16(19)29-18-15-5-8-26-17(15)27-12-28-18/h1-5,8,12,16H,6-7,9-11H2,(H2,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 105n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361998
PNG
(US10221182, Compound C-1.36)
Show SMILES FC(F)(F)c1cccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(6-4-12-2-1-3-13(8-12)19(22,23)24)7-5-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-3,8-9,11,15H,4-7,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 291n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361998
PNG
(US10221182, Compound C-1.36)
Show SMILES FC(F)(F)c1cccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(6-4-12-2-1-3-13(8-12)19(22,23)24)7-5-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-3,8-9,11,15H,4-7,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 291n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361998
PNG
(US10221182, Compound C-1.36)
Show SMILES FC(F)(F)c1cccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(6-4-12-2-1-3-13(8-12)19(22,23)24)7-5-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-3,8-9,11,15H,4-7,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 291n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361997
PNG
(US10221182, Compound C-1.35)
Show SMILES Fc1ccc(F)c(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c1
Show InChI InChI=1S/C18H18F4N6/c19-12-1-2-14(20)11(7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 329n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361997
PNG
(US10221182, Compound C-1.35)
Show SMILES Fc1ccc(F)c(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c1
Show InChI InChI=1S/C18H18F4N6/c19-12-1-2-14(20)11(7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 329n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361987
PNG
(US10221182, Compound C-3.5)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cn1
Show InChI InChI=1S/C18H18F5N7/c19-17(20)9-30(5-3-11-1-2-14(24-7-11)18(21,22)23)6-4-13(17)28-15-12-8-27-29-16(12)26-10-25-15/h1-2,7-8,10,13H,3-6,9H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 822n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361987
PNG
(US10221182, Compound C-3.5)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cn1
Show InChI InChI=1S/C18H18F5N7/c19-17(20)9-30(5-3-11-1-2-14(24-7-11)18(21,22)23)6-4-13(17)28-15-12-8-27-29-16(12)26-10-25-15/h1-2,7-8,10,13H,3-6,9H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 822n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Cytochrome P450 2D6


(Homo sapiens (Human))
BDBM280739
PNG
(US10030026, Compound LX-1 | US10221182, Compound L...)
Show SMILES FC(F)(F)c1ccc(cc1)C(F)(F)CN1CCC(CC1)Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C19H19F5N6/c20-18(21,12-1-3-13(4-2-12)19(22,23)24)10-30-7-5-14(6-8-30)28-16-15-9-27-29-17(15)26-11-25-16/h1-4,9,11,14H,5-8,10H2,(H2,25,26,27,28,29)
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.00E+3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
Inhibitory activities of test compounds on 5 major isoforms of CYP P450 were evaluated by using pooled human liver microsome (HLM, purchased from BD ...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361996
PNG
(US10221182, Compound C-4.5)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ccc34)C(F)(F)C2)cn1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-4-12-1-2-15(26-9-12)19(22,23)24)8-5-14(18)29-17-13-3-6-25-16(13)27-11-28-17/h1-3,6,9,11,14H,4-5,7-8,10H2,(H2,25,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.74E+3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361996
PNG
(US10221182, Compound C-4.5)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ccc34)C(F)(F)C2)cn1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-4-12-1-2-15(26-9-12)19(22,23)24)8-5-14(18)29-17-13-3-6-25-16(13)27-11-28-17/h1-3,6,9,11,14H,4-5,7-8,10H2,(H2,25,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.74E+3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361988
PNG
(US10221182, Compound C-3.4)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cn1
Show InChI InChI=1S/C18H21F2N7/c1-12-2-3-13(8-21-12)4-6-27-7-5-15(18(19,20)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h2-3,8-9,11,15H,4-7,10H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2.27E+3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, NMDA 2B


(Homo sapiens (Human))
BDBM361988
PNG
(US10221182, Compound C-3.4)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cn1
Show InChI InChI=1S/C18H21F2N7/c1-12-2-3-13(8-21-12)4-6-27-7-5-15(18(19,20)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h2-3,8-9,11,15H,4-7,10H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2.27E+3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Potassium voltage-gated channel subfamily H member 2


(Homo sapiens (Human))
BDBM361999
PNG
(US10221182, Compound E1-1.6 | US10221182, Compound...)
Show SMILES FC(F)[H]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H21F4N6/c20-18(21)30-13-3-1-12(2-4-13)5-7-29-8-6-15(19(22,23)10-29)27-16-14-9-26-28-17(14)25-11-24-16/h1-4,9,11,15,18H,5-8,10H2,(H2,24,25,26,27,28)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a 3.50E+3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37 C. in a humidified CO2 incubator in the grow...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Potassium voltage-gated channel subfamily H member 2


(Homo sapiens (Human))
BDBM280739
PNG
(US10030026, Compound LX-1 | US10221182, Compound L...)
Show SMILES FC(F)(F)c1ccc(cc1)C(F)(F)CN1CCC(CC1)Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C19H19F5N6/c20-18(21,12-1-3-13(4-2-12)19(22,23)24)10-30-7-5-14(6-8-30)28-16-15-9-27-29-17(15)26-11-25-16/h1-4,9,11,14H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.50E+3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37 C. in a humidified CO2 incubator in the grow...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Potassium voltage-gated channel subfamily H member 2


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7.60E+3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37 C. in a humidified CO2 incubator in the grow...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Potassium voltage-gated channel subfamily H member 2


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9.80E+3n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37 C. in a humidified CO2 incubator in the grow...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361987
PNG
(US10221182, Compound C-3.5)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cn1
Show InChI InChI=1S/C18H18F5N7/c19-17(20)9-30(5-3-11-1-2-14(24-7-11)18(21,22)23)6-4-13(17)28-15-12-8-27-29-16(12)26-10-25-15/h1-2,7-8,10,13H,3-6,9H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361984
PNG
(US10221182, Compound C-1.1 | US10221182, Compound ...)
Show SMILES FC1(F)CN(CCc2ccccc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H20F2N6/c19-18(20)11-26(8-6-13-4-2-1-3-5-13)9-7-15(18)24-16-14-10-23-25-17(14)22-12-21-16/h1-5,10,12,15H,6-9,11H2,(H2,21,22,23,24,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361997
PNG
(US10221182, Compound C-1.35)
Show SMILES Fc1ccc(F)c(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c1
Show InChI InChI=1S/C18H18F4N6/c19-12-1-2-14(20)11(7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM362005
PNG
(US10221182, Compound E1-1.11)
Show SMILES FC(F)(F)Oc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6O/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)31-19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361988
PNG
(US10221182, Compound C-3.4)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cn1
Show InChI InChI=1S/C18H21F2N7/c1-12-2-3-13(8-21-12)4-6-27-7-5-15(18(19,20)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h2-3,8-9,11,15H,4-7,10H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361998
PNG
(US10221182, Compound C-1.36)
Show SMILES FC(F)(F)c1cccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(6-4-12-2-1-3-13(8-12)19(22,23)24)7-5-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-3,8-9,11,15H,4-7,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM362003
PNG
(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Show SMILES Fc1cc(Cl)ccc1CCN1CCC(Nc2ncnc3[nH]ncc23)C(F)(F)C1
Show InChI InChI=1S/C18H18ClF3N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM362003
PNG
(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Show SMILES Fc1cc(Cl)ccc1CCN1CCC(Nc2ncnc3[nH]ncc23)C(F)(F)C1
Show InChI InChI=1S/C18H18ClF3N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361989
PNG
(US10221182, Compound E1-1.3 | US10221182, Compound...)
Show SMILES FC1(F)CN(CCc2ccc(Cl)cc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H19ClF2N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM362001
PNG
(US10221182, Compound E1-1.7 | US10221182, Compound...)
Show SMILES C[F]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F3N6/c1-22-14-4-2-13(3-5-14)6-8-28-9-7-16(19(20,21)11-28)26-17-15-10-25-27-18(15)24-12-23-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361992
PNG
(US10221182, Compound E1-1.4 | US10221182, Compound...)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F2N6/c1-13-2-4-14(5-3-13)6-8-27-9-7-16(19(20,21)11-27)25-17-15-10-24-26-18(15)23-12-22-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361985
PNG
(US10221182, Compound C-2.5)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ccc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C20H20F5N5/c21-19(22)11-30(9-6-13-1-3-14(4-2-13)20(23,24)25)10-7-16(19)29-18-15-5-8-26-17(15)27-12-28-18/h1-5,8,12,16H,6-7,9-11H2,(H2,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361999
PNG
(US10221182, Compound E1-1.6 | US10221182, Compound...)
Show SMILES FC(F)[H]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H21F4N6/c20-18(21)30-13-3-1-12(2-4-13)5-7-29-8-6-15(19(22,23)10-29)27-16-14-9-26-28-17(14)25-11-24-16/h1-4,9,11,15,18H,5-8,10H2,(H2,24,25,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361986
PNG
(US10221182, Compound C-1.33)
Show SMILES CN(C1CCN(CCc2ccc(cc2)C(F)(F)F)CC1(F)F)c1ncnc2[nH]ncc12
Show InChI InChI=1S/C20H21F5N6/c1-30(18-15-10-28-29-17(15)26-12-27-18)16-7-9-31(11-19(16,21)22)8-6-13-2-4-14(5-3-13)20(23,24)25/h2-5,10,12,16H,6-9,11H2,1H3,(H,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361989
PNG
(US10221182, Compound E1-1.3 | US10221182, Compound...)
Show SMILES FC1(F)CN(CCc2ccc(Cl)cc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H19ClF2N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361994
PNG
(US10221182, Compound C-1.15)
Show SMILES Fc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)c(F)c1
Show InChI InChI=1S/C18H18F4N6/c19-12-2-1-11(14(20)7-12)3-5-28-6-4-15(18(21,22)9-28)26-16-13-8-25-27-17(13)24-10-23-16/h1-2,7-8,10,15H,3-6,9H2,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361995
PNG
(US10221182, Compound C-1.34)
Show SMILES Cc1n[nH]c2ncnc(NC3CCN(CCc4ccc(cc4)C(F)(F)F)CC3(F)F)c12
Show InChI InChI=1S/C20H21F5N6/c1-12-16-17(26-11-27-18(16)30-29-12)28-15-7-9-31(10-19(15,21)22)8-6-13-2-4-14(5-3-13)20(23,24)25/h2-5,11,15H,6-10H2,1H3,(H2,26,27,28,29,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM362001
PNG
(US10221182, Compound E1-1.7 | US10221182, Compound...)
Show SMILES C[F]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F3N6/c1-22-14-4-2-13(3-5-14)6-8-28-9-7-16(19(20,21)11-28)26-17-15-10-25-27-18(15)24-12-23-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,23,24,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361996
PNG
(US10221182, Compound C-4.5)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ccc34)C(F)(F)C2)cn1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-4-12-1-2-15(26-9-12)19(22,23)24)8-5-14(18)29-17-13-3-6-25-16(13)27-11-28-17/h1-3,6,9,11,14H,4-5,7-8,10H2,(H2,25,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361984
PNG
(US10221182, Compound C-1.1 | US10221182, Compound ...)
Show SMILES FC1(F)CN(CCc2ccccc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H20F2N6/c19-18(20)11-26(8-6-13-4-2-1-3-5-13)9-7-15(18)24-16-14-10-23-25-17(14)22-12-21-16/h1-5,10,12,15H,6-9,11H2,(H2,21,22,23,24,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361991
PNG
(US10221182, Compound C-1.2)
Show SMILES Fc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C18H19F3N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361992
PNG
(US10221182, Compound E1-1.4 | US10221182, Compound...)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F2N6/c1-13-2-4-14(5-3-13)6-8-27-9-7-16(19(20,21)11-27)25-17-15-10-24-26-18(15)23-12-22-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Glutamate [NMDA] receptor


(Homo sapiens (Human))
BDBM361999
PNG
(US10221182, Compound E1-1.6 | US10221182, Compound...)
Show SMILES FC(F)[H]c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H21F4N6/c20-18(21)30-13-3-1-12(2-4-13)5-7-29-8-6-15(19(22,23)10-29)27-16-14-9-26-28-17(14)25-11-24-16/h1-4,9,11,15,18H,5-8,10H2,(H2,24,25,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
TBD


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Cytochrome P450 2D6


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.52E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
Inhibitory activities of test compounds on 5 major isoforms of CYP P450 were evaluated by using pooled human liver microsome (HLM, purchased from BD ...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Potassium voltage-gated channel subfamily H member 2


(Homo sapiens (Human))
BDBM361992
PNG
(US10221182, Compound E1-1.4 | US10221182, Compound...)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F2N6/c1-13-2-4-14(5-3-13)6-8-27-9-7-16(19(20,21)11-27)25-17-15-10-24-26-18(15)23-12-22-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.55E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37 C. in a humidified CO2 incubator in the grow...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Potassium voltage-gated channel subfamily H member 2


(Homo sapiens (Human))
BDBM361991
PNG
(US10221182, Compound C-1.2)
Show SMILES Fc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C18H19F3N6/c19-13-3-1-12(2-4-13)5-7-27-8-6-15(18(20,21)10-27)25-16-14-9-24-26-17(14)23-11-22-16/h1-4,9,11,15H,5-8,10H2,(H2,22,23,24,25,26)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.63E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37 C. in a humidified CO2 incubator in the grow...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Potassium voltage-gated channel subfamily H member 2


(Homo sapiens (Human))
BDBM361992
PNG
(US10221182, Compound E1-1.4 | US10221182, Compound...)
Show SMILES Cc1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H22F2N6/c1-13-2-4-14(5-3-13)6-8-27-9-7-16(19(20,21)11-27)25-17-15-10-24-26-18(15)23-12-22-17/h2-5,10,12,16H,6-9,11H2,1H3,(H2,22,23,24,25,26)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2.19E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37 C. in a humidified CO2 incubator in the grow...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Cytochrome P450 2D6


(Homo sapiens (Human))
BDBM361982
PNG
(US10221182, Compound E1-1.5 | US10221182, Compound...)
Show SMILES FC(F)(F)c1ccc(CCN2CCC(Nc3ncnc4[nH]ncc34)C(F)(F)C2)cc1
Show InChI InChI=1S/C19H19F5N6/c20-18(21)10-30(7-5-12-1-3-13(4-2-12)19(22,23)24)8-6-15(18)28-16-14-9-27-29-17(14)26-11-25-16/h1-4,9,11,15H,5-8,10H2,(H2,25,26,27,28,29)
PDB

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3.41E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
Inhibitory activities of test compounds on 5 major isoforms of CYP P450 were evaluated by using pooled human liver microsome (HLM, purchased from BD ...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
Potassium voltage-gated channel subfamily H member 2


(Homo sapiens (Human))
BDBM361984
PNG
(US10221182, Compound C-1.1 | US10221182, Compound ...)
Show SMILES FC1(F)CN(CCc2ccccc2)CCC1Nc1ncnc2[nH]ncc12
Show InChI InChI=1S/C18H20F2N6/c19-18(20)11-26(8-6-13-4-2-1-3-5-13)9-7-15(18)24-16-14-10-23-25-17(14)22-12-21-16/h1-5,10,12,15H,6-9,11H2,(H2,21,22,23,24,25)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7.10E+4n/an/an/an/an/an/a



RUGEN HOLDINGS (CAYMAN) LIMITED

US Patent


Assay Description
The assay was performed on hERG channel stably expressed in HEK293 cells. The cells were cultured at 37 C. in a humidified CO2 incubator in the grow...


US Patent US10221182 (2019)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%